Organization
Changsha, China
7 abstracts
Abstract
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III NSCLC (TRAILBLAZER): Efficacy, safety and feasibility of surgical conversion outcomes from a proof-of-concept, phase 2 trial.Org: Zhengzhou, China, Tianjin Medical University Cancer Institute and Hospital/National Clinical Research Center for Cancer, Luoyang, China, Hunan Provincial Tumor Hospital, Changsha, China,
Abstract
The efficacy and safety of toripalimab combined with anlotinib in the first-line treatment of Chinese patients with metastatic melanoma.Org: Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, Union Hospital, Tongji Medical College Huazhong University of Science and Technology, Huazhong University of Science and Technology Union Shenzhen Hospital, Wuhan, China,
Abstract
Efficacy and safety of neoadjuvant therapy with disitamab vedotin plus toripalimab in treating muscle invasive urothelial bladder cancer followed by selective bladder-preserving or radical cystectomy.Org: Department of Urology, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China, Xiangya Hospital of Central South University, Changsha, China, Central South University, Changsha, China,
Abstract
Association between psychological distress and treatment efficacy in patients with newly diagnosed SCLC.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China,
Abstract
Guideline concordance of recurrence risk assessment for early breast cancer in a county-level setting in China.Org: The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China, The People's Hospital of Liuyang, Changsha, China, Changsha, China, Inner Mongolia Forestry General Hospital, Hulunbeier, China,
Abstract
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study.Org: Department of Medical Oncology Gastroenterology and Urology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China, Changsha, China,
Abstract
Washing solution of tissue biopsy compared with paraffin-embedded tissue for NSCLC gene test.Org: The Second Xiangya Hospital of Central South University, Central South University, Changsha, China, Changsha, China,